Beth A Tippett Barr1, Monique van Lettow2, Joep J van Oosterhout3, Megan Landes4, Ray W Shiraishi5, Ermias Amene6, Erik Schouten7, Nellie Wadonda-Kabondo8, Sundeep Gupta9, Andrew F Auld8, Thokozani Kalua10, Andreas Jahn11. 1. Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi; Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya. Electronic address: btippettbarr@cdc.gov. 2. Dignitas International, Zomba, Malawi. 3. Dignitas International, Zomba, Malawi; Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi. 4. Dignitas International, Zomba, Malawi; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. 5. Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. 6. Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA; ICF International, Atlanta, GA, USA. 7. Management Sciences for Health, Lilongwe, Malawi. 8. Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi. 9. Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. 10. Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi. 11. Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi; International Training and Education Center for Health, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: Routine data from Malawi's prevention of mother-to-child transmission (MTCT) option B+ programme suggest high uptake of antiretroviral therapy (ART) among pregnant women. Malawi's Ministry of Health led the National Evaluation of Malawi's PMTCT Program to obtain nationally representative data on maternal ART coverage and prevention of MTCT effectiveness. Here, we present the early transmission data for infants aged 4-12 weeks. METHODS: We used a multistage cluster design to recruit a nationally representative sample of HIV-exposed infants and their mothers in Malawi. Between October 16, 2014, and May 17, 2016, we screened for HIV in all mothers attending an under-5 vaccination or outpatient sick-child clinic with infants aged 4-26 weeks at 54 health facilities selected across ten districts and four regional sampling zones. Infants with mothers identified as HIV-infected were enrolled in the cohort. We calculated weighted MTCT rates for only the subset of infants aged 4-12 weeks at screening, thereby capturing MTCT from early pregnancy, to delivery, and early breastfeeding. We collected data on maternal and infant demographics and self-reported use of HIV services, ART, and antenatal clinics. We tested HIV-exposed infants for the virus and assessed associations of certain variables with infant HIV status. FINDINGS: We confirmed HIV exposure in 3542 (10·4%) of 33 980 mother (guardian)-infant pairs with infants aged 4-26 weeks. Of those, 2530 (2514 mothers and 16 guardians) had infants aged 4-12 weeks at the time of screening (2498 singlets and 32 twins). We excluded 25 infants from the analysis because no information was available about their HIV status. 91·3% (95% CI 85·6-96·9) of mothers were on ART during pregnancy. The MTCT rate was 3·7% (2·3-6·0) overall and ranged from 1·4% (0·4-4·4) in women who initiated ART before pregnancy to 19·9% (13·4-28·6) in women not on ART. In multivariable logistic regression analysis, the odds of early MTCT were higher in mothers starting ART post partum (adjusted odds ratio 16·7, 95% CI 1·6-171·5; p=0·022) and in those not on ART with an unknown HIV status during pregnancy (19·1, 8·5-43·0; p<0·0001) than in mothers on ART before pregnancy. Among HIV-exposed infants, 98·0% (95% CI 96·9-99·1) were reported by the mother to have received infant nevirapine prophylaxis, and only 45·6% (34·8-56·4) were already enrolled in an exposed infant HIV care clinic at the time of study screening. INTERPRETATION: These data suggest that Malawi's decentralisation of ART services has resulted in higher ART coverage and lower early MTCT. However, the uptake of services for HIV-exposed infants remains suboptimal. FUNDING: President's Emergency Plan for AIDS Relief.
BACKGROUND: Routine data from Malawi's prevention of mother-to-child transmission (MTCT) option B+ programme suggest high uptake of antiretroviral therapy (ART) among pregnant women. Malawi's Ministry of Health led the National Evaluation of Malawi's PMTCT Program to obtain nationally representative data on maternal ART coverage and prevention of MTCT effectiveness. Here, we present the early transmission data for infants aged 4-12 weeks. METHODS: We used a multistage cluster design to recruit a nationally representative sample of HIV-exposed infants and their mothers in Malawi. Between October 16, 2014, and May 17, 2016, we screened for HIV in all mothers attending an under-5 vaccination or outpatient sick-child clinic with infants aged 4-26 weeks at 54 health facilities selected across ten districts and four regional sampling zones. Infants with mothers identified as HIV-infected were enrolled in the cohort. We calculated weighted MTCT rates for only the subset of infants aged 4-12 weeks at screening, thereby capturing MTCT from early pregnancy, to delivery, and early breastfeeding. We collected data on maternal and infant demographics and self-reported use of HIV services, ART, and antenatal clinics. We tested HIV-exposed infants for the virus and assessed associations of certain variables with infant HIV status. FINDINGS: We confirmed HIV exposure in 3542 (10·4%) of 33 980 mother (guardian)-infant pairs with infants aged 4-26 weeks. Of those, 2530 (2514 mothers and 16 guardians) had infants aged 4-12 weeks at the time of screening (2498 singlets and 32 twins). We excluded 25 infants from the analysis because no information was available about their HIV status. 91·3% (95% CI 85·6-96·9) of mothers were on ART during pregnancy. The MTCT rate was 3·7% (2·3-6·0) overall and ranged from 1·4% (0·4-4·4) in women who initiated ART before pregnancy to 19·9% (13·4-28·6) in women not on ART. In multivariable logistic regression analysis, the odds of early MTCT were higher in mothers starting ART post partum (adjusted odds ratio 16·7, 95% CI 1·6-171·5; p=0·022) and in those not on ART with an unknown HIV status during pregnancy (19·1, 8·5-43·0; p<0·0001) than in mothers on ART before pregnancy. Among HIV-exposed infants, 98·0% (95% CI 96·9-99·1) were reported by the mother to have received infantnevirapine prophylaxis, and only 45·6% (34·8-56·4) were already enrolled in an exposed infant HIV care clinic at the time of study screening. INTERPRETATION: These data suggest that Malawi's decentralisation of ART services has resulted in higher ART coverage and lower early MTCT. However, the uptake of services for HIV-exposed infants remains suboptimal. FUNDING: President's Emergency Plan for AIDS Relief.
Authors: Lyson Tenthani; Andreas D Haas; Matthias Egger; Joep J Van Oosterhout; Andreas Jahn; Frank Chimbwandira; Kali Tal; Landon Myer; Janne Estill; Olivia Keiser Journal: J Acquir Immune Defic Syndr Date: 2015-08-15 Impact factor: 3.731
Authors: Scott E Kellerman; Saeed Ahmed; Theresa Feeley-Summerl; Jonathan Jay; Maria Kim; B Ryan Phelps; Nandita Sugandhi; Erik Schouten; Mike Tolle; Fatima Tsiouris Journal: AIDS Date: 2013-11 Impact factor: 4.177
Authors: Monique van Lettow; Richard Bedell; Isabell Mayuni; Gabriel Mateyu; Megan Landes; Adrienne K Chan; Vanessa van Schoor; Teferi Beyene; Anthony D Harries; Stephen Chu; Andrew Mganga; Joep J van Oosterhout Journal: J Int AIDS Soc Date: 2014-07-28 Impact factor: 5.396
Authors: Andreas D Haas; Malango T Msukwa; Matthias Egger; Lyson Tenthani; Hannock Tweya; Andreas Jahn; Oliver J Gadabu; Kali Tal; Luisa Salazar-Vizcaya; Janne Estill; Adrian Spoerri; Nozgechi Phiri; Frank Chimbwandira; Joep J van Oosterhout; Olivia Keiser Journal: Clin Infect Dis Date: 2016-07-26 Impact factor: 9.079
Authors: Austin Wesevich; Mina C Hosseinipour; Carol E Golin; Nuala McGrath; Mercy Tsidya; Limbikani Chimndozi; Nivedita Bhushan; Irving Hoffman; William C Miller; Nora E Rosenberg Journal: AIDS Care Date: 2019-06-25
Authors: Angela M Bengtson; Wiza Kumwenda; Mark Lurie; Brandon Klyn; Michael Owino; William C Miller; Vivian Go; Mina C Hosseinipour Journal: AIDS Behav Date: 2020-02
Authors: H J Zar; D P Moore; S Andronikou; A C Argent; T Avenant; C Cohen; R J Green; G Itzikowitz; P Jeena; R Masekela; M P Nicol; A Pillay; G Reubenson; S A Madhi Journal: Afr J Thorac Crit Care Med Date: 2020-10-13
Authors: Coleen K Cunningham; Elizabeth J McFarland; R Leavitt Morrison; Edmund V Capparelli; Jeffrey T Safrit; Lynne M Mofenson; Bonnie Mathieson; Megan E Valentine; Charlotte Perlowski; Betsy Smith; Rohan Hazra; Lynette Purdue; Petronella Muresan; Paul A Harding; Tapiwa Mbengeranwa; Lisa-Gaye Robinson; Andrew Wiznia; Gerhard Theron; Bob Lin; Robert T Bailer; John R Mascola; Barney S Graham Journal: J Infect Dis Date: 2020-07-23 Impact factor: 7.759
Authors: Elizabeth J McFarland; Coleen K Cunningham; Petronella Muresan; Edmund V Capparelli; Charlotte Perlowski; Patricia Morgan; Betsy Smith; Rohan Hazra; Lynette Purdue; Paul A Harding; Gerhard Theron; Hilda Mujuru; Allison Agwu; Murli Purswani; Mobeen H Rathore; Britta Flach; Alison Taylor; Bob C Lin; Adrian B McDermott; John R Mascola; Barney S Graham Journal: J Infect Dis Date: 2021-12-01 Impact factor: 7.759
Authors: Lauren M Hill; Friday Saidi; Kellie Freeborn; K Rivet Amico; Nora E Rosenberg; Suzanne Maman; Twambilile Phanga; Mercy Tsidya; Sara Chirwa; Chifundo Zimba; Wilbroad Mutale; Benjamin H Chi Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240
Authors: Friday Saidi; Wilbroad Mutale; Kellie Freeborn; Nora E Rosenberg; Lauren Aiko Graybill; Suzanne Maman; K Rivet Amico; Katie R Mollan; Twambilile Phanga; Beteniko Milala; Lauren M Hill; Allison M Gottwalt; Sam Phiri; Thoko Kalua; Benjamin H Chi Journal: BMJ Open Date: 2021-06-30 Impact factor: 2.692